NPF Submits Comments in Response to the CMS Proposed Rule to Support Value-Based Purchasing in Medicaid


NPF appreciates the Administration’s continued focus on ways to reduce the financial burdens that pharmaceutical costs place on our community, and we appreciate this proposal promoting value-based payment arrangements. While NPF supports the overall aim of the proposed rule to remove regulatory barriers for value-based payment contracts, our letter also expresses concerns regarding other provisions that could negatively affect patient access to potentially life-changing treatments. Our comments and concerns are further outlined in the letter below.

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorCommunity Health Charities logo

Copyright © 1996-2023 National Psoriasis Foundation/USA

Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).

NPF does not endorse or accept any responsibility for the content of external websites.

NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.